LabGenomics. Co., Ltd. Q3 consolidated revenue KRW 13.7 billion, operating loss KRW 3.5 billion
LAI summary · Not investment advice
Labgenomics sold KRW 13.7 billion in Q3 and lost KRW 3.5 billion from its main business, versus a loss of KRW 2.1 billion a year earlier.
Operating profit · 3 months
KRW -3.5 billion
Key facts
- Revenue (3 months)
- KRW 13.7 billion
- Net income (3 months)
- KRW -5.2 billion
- Period
- Q3 (cumulative 2026.01.01 ~ 2026.09.30)
- Revenue (prior-year 3 months)
- KRW 23.0 billion
- Revenue (year to date)
- KRW 47.3 billion
- Operating profit (prior-year 3 months)
- KRW -2.1 billion
- Operating profit (year to date)
- KRW -14.5 billion
- Net income (prior-year 3 months)
- KRW -3.5 billion
- Net income (year to date)
- KRW -12.5 billion
Commentary
AI commentary · Not investment advice
What happened
Lab Genomics filed its quarterly report for the third quarter of 2026, on a consolidated basis. Sales for the latest 3 months were KRW 13.66 billion, down 40.7% from KRW 23.04 billion a year earlier. Cumulative sales this year are KRW 47.34 billion.
In the company's terms
Operating profit (profit from the core business) was a loss of KRW 3.46 billion in the latest 3 months. A year earlier, the loss was KRW 2.12 billion. The cumulative operating loss this year is KRW 14.50 billion.
What changes for shareholders
Net income (the final profit after taxes and other items) was a loss of KRW 5.21 billion in the latest 3 months. A year earlier, the loss was KRW 3.48 billion. The cumulative net loss this year is KRW 12.46 billion.
Comments
No comments yet
Comments from shareholders will appear here.
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist